Gastroenterology CE Activities

Meeting the Challenges of IBD Management in the Era of COVID-19: A Panel Case Review & Discussion

0.50 CE Credit(s)

Crohn’s Disease: Targets, Risk Stratification, and Clinical Tools: A Care Team Forum

1.00 CE Credit(s)

Assessing the Potential Patient Care Implications of New Data in Eosinophilic Esophagitis: Clinical Transfers®

0.50 CE Credit(s)

Empowered Crohn’s Disease Care: Targets, Tools, and Talking to Patients

0.75 CE Credit(s)

Taking Stock of Current Options and Emerging Approaches for the Management of EoE

0.50 CE Credit(s)

Getting the Diagnosis Right Early: Clinical Pearls for Identifying EoE in Children and Adults

0.25 CE Credit(s)

RMEI Presentations

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

When the Patient Voice is Heard in Education, Does the Clinician Listen?

When the Patient Voice is Heard in Education, Does the Clinican Listen? Dual Track Patient/Provider Education in IBD Incorporating Patients as Learners and Faculty

The Gastroenterology Learner Pathway in IBD: An Outcomes-Based Iterative Approach to IBD Education Using Advanced Analytics and Predictive Modeling to Sustain Behavioral Change

LATEST Gastroentrology ARTICLES

Latest Gastroentrology Articles

Pediatric Achalasia October 28, 2021
Figure 1.
Nonalcoholic Steatohepatitis — Opportunities and Challenges October 21, 2021
Nonalcoholic steatohepatitis (NASH), the progressive form of nonalcoholic fatty liver disease, has superseded hepatitis C as the main cause of cirrhosis and the main reason for liver transplantation. Contrary to hepatitis C, a liver-specific disorder caused by a single etiologic agent, NASH is a…
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH October 21, 2021
Nonalcoholic steatohepatitis (NASH), a condition that results from a combination of adipose-tissue insulin resistance, adipocytokine imbalance, and systemic inflammation, is currently a major worldwide cause of chronic liver disease, contributing to cirrhotic morbidity, hepatocellular carcinoma and…

RMEI LIGHTNING TALKS

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.

Allergy & Immunology
2021

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.